CELH
Get informed when a big investor buys or sells
+ FollowUndervalued by 221.8% based on the discounted cash flow analysis.
| Market cap | $6.96 Billion |
|---|---|
| Enterprise Value | $7.07 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.25 |
| Beta | 0.92 |
| Outstanding Shares | 254,806,000 |
| P/E Ratio | 129.62 |
|---|---|
| PEG | -204.04 |
| Price to Sales | 2.51 |
| Price to Book Ratio | 2.51 |
| Enterprise Value to Revenue | 2.32 |
| Enterprise Value to EBIT | 40.3 |
| Enterprise Value to Net Income | 99 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.62 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5806▲ 0.11% |
|---|---|
| Total Calls | 21,057,600▲ 63.26% |
| Total Puts | 12,226,000▲ 63.57% |
Holdings and activity of institutional investors.
| Ownership % | 65.86%▲ 4.18% |
|---|---|
| Total Invested | $4.97B▼ 14.66% |
| Investors Holding | 598▼ 35.00% |
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...